Your browser doesn't support javascript.
Cardiovascular/Stroke Risk Stratification in Parkinson's Disease Patients Using Atherosclerosis Pathway and Artificial Intelligence Paradigm: A Systematic Review.
Suri, Jasjit S; Paul, Sudip; Maindarkar, Maheshrao A; Puvvula, Anudeep; Saxena, Sanjay; Saba, Luca; Turk, Monika; Laird, John R; Khanna, Narendra N; Viskovic, Klaudija; Singh, Inder M; Kalra, Mannudeep; Krishnan, Padukode R; Johri, Amer; Paraskevas, Kosmas I.
  • Suri JS; Stroke Monitoring and Diagnostic Division, AtheroPoint™, Roseville, CA 95661, USA.
  • Paul S; Department of Biomedical Engineering, North Eastern Hill University, Shillong 793022, India.
  • Maindarkar MA; Department of Biomedical Engineering, North Eastern Hill University, Shillong 793022, India.
  • Puvvula A; Stroke Monitoring and Diagnostic Division, AtheroPoint™, Roseville, CA 95661, USA.
  • Saxena S; Annu's Hospitals for Skin & Diabetes, Gudur 524101, India.
  • Saba L; Department of CSE, International Institute of Information Technology, Bhuneshwar 751003, India.
  • Turk M; Department of Radiology, University of Cagliari, 09121 Cagliari, Italy.
  • Laird JR; Deparment of Neurology, University Medical Centre Maribor, 1262 Maribor, Slovenia.
  • Khanna NN; Heart and Vascular Institute, Adventist Health St. Helena, St. Helena, CA 94574, USA.
  • Viskovic K; Department of Cardiology, Indraprastha APOLLO Hospitals, New Delhi 110001, India.
  • Singh IM; Department of Radiology and Ultrasound, University Hospital for Infectious Diseases, 10000 Zagreb, Croatia.
  • Kalra M; Stroke Monitoring and Diagnostic Division, AtheroPoint™, Roseville, CA 95661, USA.
  • Krishnan PR; Department of Radiology, Harvard Medical School, Boston, MA 02115, USA.
  • Johri A; Neurology Department, Fortis Hospital, Bangalore 560010, India.
  • Paraskevas KI; Department of Medicine, Division of Cardiology, Queen's University, Kingston, ON K7L 3N6, Canada.
Metabolites ; 12(4)2022 Mar 31.
Article in English | MEDLINE | ID: covidwho-1810024
ABSTRACT
Parkinson's disease (PD) is a severe, incurable, and costly condition leading to heart failure. The link between PD and cardiovascular disease (CVD) is not available, leading to controversies and poor prognosis. Artificial Intelligence (AI) has already shown promise for CVD/stroke risk stratification. However, due to a lack of sample size, comorbidity, insufficient validation, clinical examination, and a lack of big data configuration, there have been no well-explained bias-free AI investigations to establish the CVD/Stroke risk stratification in the PD framework. The study has two

objectives:

(i) to establish a solid link between PD and CVD/stroke; and (ii) to use the AI paradigm to examine a well-defined CVD/stroke risk stratification in the PD framework. The PRISMA search strategy selected 223 studies for CVD/stroke risk, of which 54 and 44 studies were related to the link between PD-CVD, and PD-stroke, respectively, 59 studies for joint PD-CVD-Stroke framework, and 66 studies were only for the early PD diagnosis without CVD/stroke link. Sequential biological links were used for establishing the hypothesis. For AI design, PD risk factors as covariates along with CVD/stroke as the gold standard were used for predicting the CVD/stroke risk. The most fundamental cause of CVD/stroke damage due to PD is cardiac autonomic dysfunction due to neurodegeneration that leads to heart failure and its edema, and this validated our hypothesis. Finally, we present the novel AI solutions for CVD/stroke risk prediction in the PD framework. The study also recommends strategies for removing the bias in AI for CVD/stroke risk prediction using the PD framework.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study / Reviews / Systematic review/Meta Analysis Language: English Year: 2022 Document Type: Article Affiliation country: Metabo12040312

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study / Reviews / Systematic review/Meta Analysis Language: English Year: 2022 Document Type: Article Affiliation country: Metabo12040312